From the Archives: Next-Gen MRD Testing: Foresight’s Leap in Sensitivity with Jake Chabon and Dave Kurtz
Jake Chabon and David Kurtz, co-founders of Foresight Diagnostics, explain their advanced MRD testing technology, PhasED-Seq, which achieves high sensitivity by tracking phased variants. They discuss its impact on NCCN guidelines and its future application in treating various…